Table 5.
Arrhythmia-related clinical events
Cumulative incidence—% (number of events) | Median time-to-event—months [interquartile range] | |||||
---|---|---|---|---|---|---|
3 months | 6 months | 1 year | 2 years | 3 years | ||
Composite endpoint | 5.0 (1) | 15.0 (3) | 25.0 (5) | 50.0 (10) | 60.0 (12) | 25.7 [12.9–34.6] |
Individual components | ||||||
Electrical cardioversion | 5.0 (1) | 10.0 (2) | 20.0 (4) | 35.0 (7) | 35.0 (7) | NA |
Chemical cardioversion | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.0 (0) | NA |
Pulmonary vein isolation | 0.0 (0) | 0.0 (0) | 0.0 (0) | 5.0 (1) | 10.3 (2) | NA |
MAZE procedure | 0.0 (0) | 0.0 (0) | 0.0 (0) | 5.0 (1) | 16.7 (3) | NA |
First uptitration of antiarrhythmic drugs as compared to baseline | 0.0 (0) | 5.0 (1) | 5.0 (1) | 35.0 (7) | 47.5 (9) | NA |
First increase in EHRA class as compared to baseline | 0.0 (0) | 0.0 (0) | 5.0 (1) | 5.0 (1) | 18.7 (3) | NA |